Table 2

Reactivity of proximal and distal segments and coronary stenoses to substance (sub) P before and afterl-arginine infusion

SalineSub P1 (5.6 pmol)Sub P1 (27.8 pmol)l-arginine (150 μmol)Sub P2 (5.6 pmol)Sub P2 (27.8pmol)
Coronary artery disease
Proximal (n = 23)3.08 (0.13)3.28 (0.14)3.29 (0.12)3.27 (0.13)3.34 (0.15)3.39 (0.13)2-151
(0.6 (0.3)%)(7.1 (1.5)%)(8.6 (1.7)%)(8.5 (1.1)%)(8.4 (1.5)%)(12.7 (1.8)%)
Distal (n = 26)1.43 (0.05) 1.60 (0.06)2-150 1.61 (0.07)2-150 1.50 (0.07)1.65 (0.07)** 1.70 (0.07)2-151
(0.7 (0.5)%)(14.2 (2.5)%)(15.3 (2.3)%)(6.7 (1.3)%)(15.7 (2.1)%)(21.8 (2.8)%)
Stenoses (n = 14)1.48 (0.14) 1.64 (0.16) 1.72 (0.19) 1.70 (0.18)1.82 (0.16)2-151 1.84 (0.19)2-151
(0.8 (0.6)%)(10.9 (2.5)%)(11.8 (3.3)%)(11.7 (2.3)%)(18.3 (2.8)%)(20.3 (2.7)%)
Normal coronary arteries
Proximal (n = 9)3.05 (0.27)3.25 (0.25)3.40 (0.23)3.20 (0.28)3.35 (0.24)†† 3.49 (0.24)
(0.9 (0.5)%)(8.6 (3.6)%)(14.4 (4.3)%)(10.4 (3.4)%)(12.4 (3.7)%)(17.4 (4.1)%)
Distal (n = 14)1.50 (0.04) 1.68 (0.07)2-150 1.71 (0.05)1.55 (0.06)1.69 (0.01)1.79 (0.06)††
(0.6 (0.7)%)(13.4 (4.0)%)(15.5 (2.3)%)(6.5 (2.9)%)(14.6 (3.8)%)(20.6 (2.9)%)
  • Values are mean (SEM) luminal diameter in mm (mean (SEM) percentage change from baseline).

  • p < 0.01 all responses to substance P vnormal saline in both groups.

  • 2-150 p < 0.05, **p < 0.01 v proximal segments.

  • 2-151 p < 0.01, ††p < 0.05 v the pre-l-arginine responses.

  • 1 = before l-arginine administration; 2 = afterl-arginine administration; CA, coronary arteries.